What is Direct Biologics worth?
$675.0Mlast known valuation
Direct Biologics last raised $11.6M in its Early Stage VC (Oct 2022).
Free account
See the evidence behind this price
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Direct Biologics
Create free account
No card required
Funding history
1 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Oct 2022 | Early Stage VC | $11.6M | ▮ | ▮ |
How Direct Biologics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Direct Biologics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is Direct Biologics worth?
- Direct Biologics's last known valuation is $675.0M.
- How much has Direct Biologics raised?
- Direct Biologics has raised $3.5M in total funding across 1 recorded rounds.
- When did Direct Biologics last raise?
- Direct Biologics last raised in Oct 2022 (Early Stage VC), raising $11.6M.